nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—SLC19A1—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.131	0.131	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.0829	0.0829	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.0571	0.0571	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.0533	0.0533	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.0466	0.0466	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.0404	0.0404	CbGpPWpGaD
Pralatrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—abdominal aortic aneurysm	0.0373	0.0373	CbGpPWpGaD
Pralatrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—abdominal aortic aneurysm	0.0317	0.0317	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.0295	0.0295	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.0203	0.0203	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.0189	0.0189	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—SERPINE1—abdominal aortic aneurysm	0.0175	0.0175	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—LRP1—abdominal aortic aneurysm	0.0164	0.0164	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—CDKN2A—abdominal aortic aneurysm	0.0163	0.0163	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—SERPINE1—abdominal aortic aneurysm	0.0152	0.0152	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.0144	0.0144	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AAAS—abdominal aortic aneurysm	0.0143	0.0143	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN2A—abdominal aortic aneurysm	0.0142	0.0142	CbGpPWpGaD
Pralatrexate—FPGS—Disease—LRP1—abdominal aortic aneurysm	0.014	0.014	CbGpPWpGaD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—abdominal aortic aneurysm	0.0133	0.0133	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—LDLR—abdominal aortic aneurysm	0.0125	0.0125	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AAAS—abdominal aortic aneurysm	0.0121	0.0121	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AAAS—abdominal aortic aneurysm	0.0119	0.0119	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NCF1—abdominal aortic aneurysm	0.0117	0.0117	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—AAAS—abdominal aortic aneurysm	0.011	0.011	CbGpPWpGaD
Pralatrexate—FPGS—Disease—LDLR—abdominal aortic aneurysm	0.0106	0.0106	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—LDLR—abdominal aortic aneurysm	0.0104	0.0104	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AAAS—abdominal aortic aneurysm	0.0102	0.0102	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—abdominal aortic aneurysm	0.00998	0.00998	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NCF1—abdominal aortic aneurysm	0.00991	0.00991	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—AAAS—abdominal aortic aneurysm	0.00988	0.00988	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—AAAS—abdominal aortic aneurysm	0.00964	0.00964	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—LDLR—abdominal aortic aneurysm	0.00887	0.00887	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN2A—abdominal aortic aneurysm	0.00871	0.00871	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—AAAS—abdominal aortic aneurysm	0.00862	0.00862	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—NOS2—abdominal aortic aneurysm	0.00805	0.00805	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—SERPINE1—abdominal aortic aneurysm	0.00678	0.00678	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—APOE—abdominal aortic aneurysm	0.00645	0.00645	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00617	0.00617	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS2—abdominal aortic aneurysm	0.00601	0.00601	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LRP1—abdominal aortic aneurysm	0.00584	0.00584	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AGT—abdominal aortic aneurysm	0.00551	0.00551	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APOE—abdominal aortic aneurysm	0.00548	0.00548	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—APOE—abdominal aortic aneurysm	0.0054	0.0054	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00535	0.00535	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS2—abdominal aortic aneurysm	0.00511	0.00511	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AAAS—abdominal aortic aneurysm	0.00507	0.00507	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SERPINE1—abdominal aortic aneurysm	0.00506	0.00506	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AGT—abdominal aortic aneurysm	0.00469	0.00469	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—APOE—abdominal aortic aneurysm	0.00459	0.00459	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LDLR—abdominal aortic aneurysm	0.00442	0.00442	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—abdominal aortic aneurysm	0.00442	0.00442	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SERPINE1—abdominal aortic aneurysm	0.0043	0.0043	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AAAS—abdominal aortic aneurysm	0.00424	0.00424	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NCF1—abdominal aortic aneurysm	0.00414	0.00414	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—abdominal aortic aneurysm	0.00376	0.00376	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—LDLR—abdominal aortic aneurysm	0.0037	0.0037	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AAAS—abdominal aortic aneurysm	0.0037	0.0037	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—abdominal aortic aneurysm	0.0037	0.0037	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.00366	0.00366	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.00327	0.00327	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—LDLR—abdominal aortic aneurysm	0.00323	0.00323	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.00319	0.00319	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—abdominal aortic aneurysm	0.00315	0.00315	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.00286	0.00286	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOE—abdominal aortic aneurysm	0.00229	0.00229	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS2—abdominal aortic aneurysm	0.00213	0.00213	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AGT—abdominal aortic aneurysm	0.00196	0.00196	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOE—abdominal aortic aneurysm	0.00192	0.00192	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SERPINE1—abdominal aortic aneurysm	0.0018	0.0018	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AGT—abdominal aortic aneurysm	0.00171	0.00171	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOE—abdominal aortic aneurysm	0.00167	0.00167	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—abdominal aortic aneurysm	0.00157	0.00157	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—abdominal aortic aneurysm	0.00131	0.00131	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—abdominal aortic aneurysm	0.00115	0.00115	CbGpPWpGaD
